Advertisement

Topics

Biosceptre Company Profile

10:38 EST 16th December 2018 | BioPortfolio

Biosceptre has identified a pan-cancer target, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs directed at the nf-P2X7 target have the potential to redefine cancer therapy. The Company has raised AUD33m and will be raising further capital through both existing and new investors. Biosceptre has a rigorous, international patent portfolio extending to 2032, providing broad protection of the target and specific protection of antibody products. The Company is developing therapeutics and diagnostics to bind nf-P2X7, with the core of product development in topical and systemic cancer drugs. Biosceptreis also developing an immuno-oncology vaccine, through an existing collaboration, and is in discussions with developmental partners to develop diagnostic and imaging technologies to detect and monitor cancer. Biosceptre is supported by a world-class scientific advisory board, the members of which have been central in the development of numerous, highly successful, biotechnology companies and products. The Company has the team, capital, and plan to create substantial value from this unique, patent-protected, technology. The business is headquartered in Cambridge, UK with additional research facilities in Sydney, Australia.


News Articles [5 Associated News Articles listed on BioPortfolio]

Biosceptre: A New Approach to Cancer Research

In this episode of PharmaTelevision News Review, Fintan Walton talks with Alan Bootes, Chairman of Biosceptre International Ltd. Filmed at AusBiotech 2009, they discuss: • Biosceptre's unconventiona...

Biosceptre: Cliff Holloway discusses developing their antibodies to nf-P2X7 for therapeutic and diagnostic applications in cancer

In this episode of PharmaTelevision News Review, Fintan Walton talks to Cliff Holloway, CEO of BioSceptre.

Biosceptre: Promise beyond cancer

nfP2X7 is a variant of the P2X7 transmembrane ligand gated ion channel, and has been identified and characterized by Biosceptre as a significant new oncology therapy target. Daniel Barton discusses wi...

Biosceptre International Ltd Product Pipeline Analysis, 2018 Update [Report Updated: 20072018] Prices from USD $750

SummaryBiosceptre International Ltd Biosceptre is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging te...

Biosceptre International Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryBiosceptre International Ltd Biosceptre is a biotechnology company that develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Biosceptre

Biosceptre has identified a pan-cancer target, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs di...

More Information about "Biosceptre" on BioPortfolio

We have published hundreds of Biosceptre news stories on BioPortfolio along with dozens of Biosceptre Clinical Trials and PubMed Articles about Biosceptre for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biosceptre Companies in our database. You can also find out about relevant Biosceptre Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record